Search

everythinglearnresearchcommunity

for

Search:↓

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Dutasteride injections can help treat hair loss in men and women.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

Chronic ethanol increases certain brain receptor levels, influenced by steroids and protein changes.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

High levels of phenyl glycidyl ether vapor caused hair loss in rats.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Spironolactone is a promising alternative to antibiotics for treating acne in adult females.

Tofacitinib is effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

The compound 4c effectively inhibits the enzyme linked to hair loss.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.